Questionnaire Survey of Perceived Satisfaction with Treatment of Patients with Psoriasis

DOI Web Site
  • Torii Hideshi
    Division of Dermatology, Social Insurance Central General Hospital
  • Nakagawa Hidemi
    Department of Dermatology, the Jikei University School of Medicine

Bibliographic Information

Other Title
  • 生物学的製剤時代における乾癬患者の治療満足度調査
  • セイブツガクテキ セイザイ ジダイ ニ オケル カンセンカンジャ ノ チリョウ マンゾクド チョウサ

Search this article

Description

The spectrum of systemic treatments has been widely enlarged since the advent of biologics. Patient-perceived treatment benefit is undoubtedly a major aim of psoriatic treatment. To clarify the degree of patient-perceived satisfaction with recently available treatments including biologics, we utilized a questionnaire survey of patients suffering from psoriasis as well as their physicians. Degree of perceived satisfaction with treatment was found to differ by severity and areas of the lesions, treatment methods, and Dermatology Life Quality Index (DLQI) scores. In addition, a gap of 27.8% in comprehensive satisfaction with treatment was detected between physicians and patients. Perceived satisfaction with treatment was further examined according to DLQI score, demonstrating a reduction in perceived satisfaction with increasing DLQI score. These results suggested that minimizing the physician-patient gap in perceived satisfaction with treatment will require maximizing patient perceived satisfaction, underscoring the need for a treatment strategy to attain a DLQI of 0 or 1. Since biologics exert strong therapeutic effects clearly distinct from those achieved with preexisting treatments, biologics are considered effective therapeutic tools to enhance patient-perceived satisfaction and to improve patientsʼimpaired QoL.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top